The Global Meningococcal Disease Vaccine Market was valued at USD 4.10 Billion in 2024 and is expected to reach USD 8.79 Billion by 2032, growing at a CAGR of 10% (2025-2032).

The Hepatitis B Vaccine market was valued at USD 3.63 Billion in 2024 and is expected to reach USD 5.27 Billion by 2032, growing at a CAGR of 4.78% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.

Future of Executive Summary Vaccine Market : Size and Share Dynamics CAGR Value The global vaccine market size was valued at USD 82.80 b...

The Pneumococcal Vaccine market was valued at USD 0.00 in 2023 and is expected to reach USD 0.00 by 2030, growing at a CAGR of 0% (2024-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.